RB001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RB001, covering 2025-07-30 to 2025-07-30. Get the full timeline:
Most recent: Clinical Trial Update: RB001 Gene Therapy Study in Children With SHANK3-related Phelan McDermid Syndrome (PMS) [NA]